Single-agent chemotherapy for non-small cell lung cancer
- 1 August 2003
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 41, S17-S22
- https://doi.org/10.1016/s0169-5002(03)90521-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Weekly topotecan in the management of lung cancerLung Cancer, 2003
- Prospective Phase II Study of Single-Agent Gemcitabine in Untreated Elderly Patients With Stage IIIB/IV Non–Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 2001
- Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinomaCancer, 2000
- A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancerLung Cancer, 2000
- Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer A multicenter phase II studyLung Cancer, 2000
- Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1999
- 126 Evaluation of topotecan (Hycamtin™) in relapsed small cell lung cancer (SCLC). A multicentre phase II studyLung Cancer, 1997
- Vinorelbine treatment of advanced non-small cell lung cancer with special emphasis on elderly patientsEuropean Journal Of Cancer, 1996
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Etoposideversus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer: Results of a prospective randomized fonicap trialCancer, 1990